Cargando…

Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells

PURPOSE: Titanium dioxide nanoparticles, 25 nm in size of crystallites (TiO(2) P25), are among the most produced nanomaterials worldwide. The broad use of TiO(2) P25 in material science has implied a request to evaluate their biological effects, especially in the lungs. Hence, the pulmonary A549 cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacova, Jana, Knotek, Petr, Kopecka, Katerina, Hromadko, Ludek, Capek, Jan, Nyvltova, Pavlina, Bruckova, Lenka, Schröterova, Ladislava, Sestakova, Blanka, Palarcik, Jiri, Motola, Martin, Cizkova, Dana, Bezrouk, Ales, Handl, Jiri, Fiala, Zdenek, Rudolf, Emil, Bilkova, Zuzana, Macak, Jan M, Rousar, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482439/
https://www.ncbi.nlm.nih.gov/pubmed/36124012
http://dx.doi.org/10.2147/IJN.S374955
_version_ 1784791455403868160
author Bacova, Jana
Knotek, Petr
Kopecka, Katerina
Hromadko, Ludek
Capek, Jan
Nyvltova, Pavlina
Bruckova, Lenka
Schröterova, Ladislava
Sestakova, Blanka
Palarcik, Jiri
Motola, Martin
Cizkova, Dana
Bezrouk, Ales
Handl, Jiri
Fiala, Zdenek
Rudolf, Emil
Bilkova, Zuzana
Macak, Jan M
Rousar, Tomas
author_facet Bacova, Jana
Knotek, Petr
Kopecka, Katerina
Hromadko, Ludek
Capek, Jan
Nyvltova, Pavlina
Bruckova, Lenka
Schröterova, Ladislava
Sestakova, Blanka
Palarcik, Jiri
Motola, Martin
Cizkova, Dana
Bezrouk, Ales
Handl, Jiri
Fiala, Zdenek
Rudolf, Emil
Bilkova, Zuzana
Macak, Jan M
Rousar, Tomas
author_sort Bacova, Jana
collection PubMed
description PURPOSE: Titanium dioxide nanoparticles, 25 nm in size of crystallites (TiO(2) P25), are among the most produced nanomaterials worldwide. The broad use of TiO(2) P25 in material science has implied a request to evaluate their biological effects, especially in the lungs. Hence, the pulmonary A549 cell line has been used to estimate the effects of TiO(2) P25. However, the reports have provided dissimilar results on caused toxicity. Surprisingly, the physicochemical factors influencing TiO(2) P25 action in biological models have not been evaluated in most reports. Thus, the objective of the present study is to characterize the preparation of TiO(2) P25 for biological testing in A549 cells and to evaluate their biological effects. METHODS: We determined the size and crystallinity of TiO(2) P25. We used four techniques for TiO(2) P25 dispersion. We estimated the colloid stability of TiO(2) P25 in distilled water, isotonic NaCl solution, and cell culture medium. We applied the optimal dispersion conditions for testing the biological effects of TiO(2) P25 (0–100 µg.mL(−1)) in A549 cells using biochemical assays (dehydrogenase activity, glutathione levels) and microscopy. RESULTS: We found that the use of fetal bovine serum in culture medium is essential to maintain sufficient colloid stability of dispersed TiO(2) P25. Under these conditions, TiO(2) P25 were unable to induce a significant impairment of A549 cells according to the results of biochemical and microscopy evaluations. When the defined parameters for the use of TiO(2) P25 in A549 cells were met, similar results on the biological effects of TiO(2) P25 were obtained in two independent cell laboratories. CONCLUSION: We optimized the experimental conditions of TiO(2) P25 preparation for toxicity testing in A549 cells. The results presented here on TiO(2) P25-induced cellular effects are reproducible. Therefore, our results can be helpful for other researchers using TiO(2) P25 as a reference material.
format Online
Article
Text
id pubmed-9482439
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94824392022-09-18 Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells Bacova, Jana Knotek, Petr Kopecka, Katerina Hromadko, Ludek Capek, Jan Nyvltova, Pavlina Bruckova, Lenka Schröterova, Ladislava Sestakova, Blanka Palarcik, Jiri Motola, Martin Cizkova, Dana Bezrouk, Ales Handl, Jiri Fiala, Zdenek Rudolf, Emil Bilkova, Zuzana Macak, Jan M Rousar, Tomas Int J Nanomedicine Original Research PURPOSE: Titanium dioxide nanoparticles, 25 nm in size of crystallites (TiO(2) P25), are among the most produced nanomaterials worldwide. The broad use of TiO(2) P25 in material science has implied a request to evaluate their biological effects, especially in the lungs. Hence, the pulmonary A549 cell line has been used to estimate the effects of TiO(2) P25. However, the reports have provided dissimilar results on caused toxicity. Surprisingly, the physicochemical factors influencing TiO(2) P25 action in biological models have not been evaluated in most reports. Thus, the objective of the present study is to characterize the preparation of TiO(2) P25 for biological testing in A549 cells and to evaluate their biological effects. METHODS: We determined the size and crystallinity of TiO(2) P25. We used four techniques for TiO(2) P25 dispersion. We estimated the colloid stability of TiO(2) P25 in distilled water, isotonic NaCl solution, and cell culture medium. We applied the optimal dispersion conditions for testing the biological effects of TiO(2) P25 (0–100 µg.mL(−1)) in A549 cells using biochemical assays (dehydrogenase activity, glutathione levels) and microscopy. RESULTS: We found that the use of fetal bovine serum in culture medium is essential to maintain sufficient colloid stability of dispersed TiO(2) P25. Under these conditions, TiO(2) P25 were unable to induce a significant impairment of A549 cells according to the results of biochemical and microscopy evaluations. When the defined parameters for the use of TiO(2) P25 in A549 cells were met, similar results on the biological effects of TiO(2) P25 were obtained in two independent cell laboratories. CONCLUSION: We optimized the experimental conditions of TiO(2) P25 preparation for toxicity testing in A549 cells. The results presented here on TiO(2) P25-induced cellular effects are reproducible. Therefore, our results can be helpful for other researchers using TiO(2) P25 as a reference material. Dove 2022-09-13 /pmc/articles/PMC9482439/ /pubmed/36124012 http://dx.doi.org/10.2147/IJN.S374955 Text en © 2022 Bacova et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bacova, Jana
Knotek, Petr
Kopecka, Katerina
Hromadko, Ludek
Capek, Jan
Nyvltova, Pavlina
Bruckova, Lenka
Schröterova, Ladislava
Sestakova, Blanka
Palarcik, Jiri
Motola, Martin
Cizkova, Dana
Bezrouk, Ales
Handl, Jiri
Fiala, Zdenek
Rudolf, Emil
Bilkova, Zuzana
Macak, Jan M
Rousar, Tomas
Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
title Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
title_full Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
title_fullStr Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
title_full_unstemmed Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
title_short Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
title_sort evaluating the use of tio(2) nanoparticles for toxicity testing in pulmonary a549 cells
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482439/
https://www.ncbi.nlm.nih.gov/pubmed/36124012
http://dx.doi.org/10.2147/IJN.S374955
work_keys_str_mv AT bacovajana evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT knotekpetr evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT kopeckakaterina evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT hromadkoludek evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT capekjan evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT nyvltovapavlina evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT bruckovalenka evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT schroterovaladislava evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT sestakovablanka evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT palarcikjiri evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT motolamartin evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT cizkovadana evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT bezroukales evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT handljiri evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT fialazdenek evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT rudolfemil evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT bilkovazuzana evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT macakjanm evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells
AT rousartomas evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells